Study #DR10-0980
IRB Research Exemption Form for Integrin Antagonists of Flexion's R0 27-2441 and RO0504183
MD Anderson Study Status
Enrolling
Treatment Agent
Description
FX002 & FX003
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Phase II/III
Physician name:
Jan Burger
Department:
Leukemia
For general questions about clinical trials:
1-888-704-1252
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.